Introduction
============

*Escherichia coli* becomes an important human pathogen in recent years owing to the emergence of new pathogenic strains \[[@R1]\]. Several diseases, such as meningitis and sepsis \[[@R2]\], diarrhoeal outbreaks \[[@R3]\] and urinary tract infections \[[@R4]\] are associated with pathogenic *Escherichia coli* (*E. coli*) strains. *E. coli* strains have been found to produce the Shiga toxin (Stx), heat-labile (LT) or heat-stable (ST) enterotoxins, cytotoxic necrotizing factors (CNF1 and CNF2) and hemolysins (α-Hly and E-Hly) \[[@R5]--[@R6]\] and are responsible for hemorrhagic colitis and haemolytic-uremic syndroms in humans \[[@R7]\]. The different strains of *E.coli* as well as bacteria belonging to different genera, e.g., *Shigella*, *Salmonella*, and *Klebsiella* show serological cross-reactions within the species \[[@R8]\]. The *E. coli* O117 strain emerged as a significant cause for septicaemia, bovine diarrhoea in new born children and human \[[@R9]\]. Together with other *E. coli* strains *E. coli* 0117 strains are responsible for pyelonephritis which is sexually transmitted by a woman that spread up to 60 to 80% of community acquired urinary tract or travelled through the bloodstream to the kidneys \[[@R10]--[@R11]\]. The *O*-specific polysaccharide of *E. coli* O117:K98:H4 is a linear pentasaccharide repeating unit consisting of D-galactosamine, D-glucose, D-galactose, and L-rhamnose ([Fig. 1](#F1){ref-type="fig"}) \[[@R12]\].

![Structure of the pentasaccharide repeating unit of the *O*-specific polysaccharide of *E. coli* O117:K98:H4.](Beilstein_J_Org_Chem-10-2724-g002){#F1}

Vaccination is the recent thrust in the drug discovery program to prevent bacterial infections. Several bacterial *O*-antigens have been chosen for the development of glycoconjugate vaccine candidates against infectious diseases \[[@R13]--[@R16]\]. As a consequence, a significant quantity of oligosaccharides is required to evaluate their immunological properties for detailed understanding of the role of *O*-antigens in the pathogenicity of the *E. coli* strains. Development of chemical synthetic strategies would be useful to get large quantities of the oligosaccharides. As a part of the ongoing studies on the synthesis of bacterial cell wall oligosaccharides \[[@R17]--[@R19]\], a straightforward synthesis of the pentasaccharide repeating unit of the *O*-specific polysaccharide of *E. coli* O117:K98:H4 as its 3-aminopropyl glycoside is presented herein ([Fig. 2](#F2){ref-type="fig"}). The 3-aminopropyl group would be suitable for attachment of the pentasaccharide to any surface or carrier proteins.

![Structure of the synthesized pentasaccharide (**1**) and its precursor intermediates.](Beilstein_J_Org_Chem-10-2724-g003){#F2}

Results and Discussion
======================

The target pentasaccharide **1** has been synthesized as its 3-aminopropyl glycoside using a combination of sequential and \[3 + 2\] block glycosylation strategy. A trisaccharide acceptor **11** and a disaccharide trichloroacetimidate donor **14** were synthesized from the appropriately protected monosaccharide intermediates **2** \[[@R20]\], **3** \[[@R21]\], **4** \[[@R22]\], **5** and **6** \[[@R23]\] ([Fig. 2](#F2){ref-type="fig"}) derived from the commercially available aldoses. Trisaccharide acceptor **11** was then glycosylated with disaccharide trichloroacetimidate donor **14** to form pentasaccharide derivative **15**, which was finally deprotected to give target pentasaccharide **1** (see below [Scheme 2](#C2){ref-type="fig"}). Some of the notable features of this synthetic strategy are (a) application of iodonium ion mediated general glycosylation conditions; (b) nitrosyl tetrafluoroborate (NOBF~4~) mediated activation of glycosyl trichloroacetimidate donor; (c) the attachment of an aminopropyl linker at the anomeric center; (d) glycosylation and removal of the *p*-methoxybenzyl (PMB) group in one-pot.

Treatment of *p*-methoxyphenyl 4,6-*O*-benzylidene-2-deoxy-2-phthalimido-β-D-galactopyranoside (**7**) \[[@R24]\] (prepared from D-galactosamine hydrochloride in six steps) with acetic anhydride in pyridine followed by regioselective reductive opening of the benzylidene acetal on treatment with sodium cyanoborohydride in the presence of HCl/Et~2~O \[[@R25]\] furnished *p*-methoxyphenyl 3-*O*-acetyl-6-*O*-benzyl-2-deoxy-2-phthalimido-β-D-galactopyranoside (**5**) in 77% yield over two steps ([Scheme 1](#C1){ref-type="fig"}).

![Reagents and conditions: (a) (i) acetic anhydride, pyridine, room temperature, 2 h; (ii) NaBH~3~CN, HCl/Et~2~O, 5 °C, 2 h, 77% overall yield.](Beilstein_J_Org_Chem-10-2724-g004){#C1}

Trisaccharide acceptor **11** could be synthesized following the reaction pathway depicted in [Scheme 2](#C2){ref-type="fig"}. Glycosylation of 3-azidopropyl 2,3,6-tri-*O*-benzyl-β-D-galactopyranoside (**2**) with the thioglycoside donor **3** in the presence of *N*-iodosuccinimide (NIS) and trimethylsilyl trifluoromethanesulfonate (TMSOTf) \[[@R26]--[@R27]\] gave disaccharide derivative **8** in 72% yield. NMR spectroscopy confirmed the formation of compound **8** \[δ 5.04 (d, *J* = 3.6 Hz, 1H, H-1~B~), 4.38 (d, *J* = 7.6 Hz, 1H, H-1~A~) in ^1^H NMR and at δ 103.9 (C-1~A~), 100.5 (C-1~B~) in ^13^C NMR spectra\]. Following an earlier report \[[@R28]\], cleavage of the benzylidene acetal from compound **8** catalyzed by perchloric acid on silica (HClO~4~/SiO~2~) \[[@R28]--[@R29]\] afforded 3-azidopropyl (2,3-di-*O*-benzyl-β-D-glucopyranosyl)-(1→4)-2,3,6-tri-*O*-benzyl-β-D-galactopyranoside (**9**) in 85% yield. Selective 6-*O*-benzoylation of compound **9** was accomplished with benzoyl cyanide \[[@R30]\] to furnish disaccharide acceptor **10** in 80% yield. Compound **10** was reacted with 3-*O*-PMB protected L-rhamnosylthioglycoside donor **4** and NIS/TfOH \[[@R26]--[@R27]\] to yield the trisaccharide derivative by an iodonium ion catalyzed glycosylation. Participation of the 2-*O*-acetyl group in donor **4** ensured the α-selectivity of the glycosylation. Following an earlier report \[[@R19]\], raising the temperature of the reaction mixture after the glycosylation led to the removal of the PMB group in the same pot \[[@R31]\] to furnish trisaccharide acceptor **11** in 77% yield. The formation of compound **11** was supported by NMR spectral analysis \[signals at δ 4.85 (d, *J* = 2.4 Hz, 1H, H-1~B~), 4.84 (brs, 1H, H-1~C~), 4.18 (d, *J* = 7.4 Hz, 1H, H-1~A~) and at δ 104.1 (C-1~A~), 98.7 (C-1~B~), 97.6 (C-1~C~) in the ^1^H and ^13^C NMR spectra respectively\]. In another experiment, coupling of 2-azido-α-D-galactosyl trichloroacetimidate derivative **6** and compound **5** in the presence of NOBF~4~ \[[@R32]\] in Et~2~O/CH~2~Cl~2~ gave disaccharide derivative **12** in 75% yield. The formation of compound **12** was confirmed by NMR spectroscopic analysis \[signals at δ 5.92 (d, *J* = 8.1 Hz, 1H, H-1~D~), 5.06 (d, *J* = 2.7 Hz, 1H, H-1~E~) in the ^1^H NMR and δ 99.1 (C-1~E~), 97.7 (C-1~D~) in the ^13^C NMR, respectively\]. Reduction of the azido groups were carried out by treatment with triphenylphosphine \[[@R33]\], then the product was acetylated using acetic anhydride and pyridine to give disaccharide derivative **13** in 84% overall yield in two steps. The anomeric PMP group of compound **13** was oxidatively cleaved using ceric(IV) ammonium nitrate (CAN) \[[@R15]\] and the hemeacetal thus obtained was reacted with trichloroacetonitrile in the presence of DBU \[[@R34]\] to afford the desired disaccharide trichloroacetimidate derivative **14** in 77% yield. It was used directly without further purification \[[@R17]\] ([Scheme 2](#C2){ref-type="fig"}). Finally, glycosylation of trisaccharide acceptor **11** with the trichloroacetimidate donor **14** in the presence of NOBF~4~ \[[@R32]\] in CH~2~Cl~2~ furnished pentasaccharide derivative **15** in 70% yield. Formation of compound **15** was supported by NMR spectral analysis \[signals at δ 5.10 (d, *J* = 3.3 Hz, 1H, H-1~E~), 5.00 (d, *J* = 2.4 Hz, 1H, H-1~B~), 4.92 (brs, 1H, H-1~C~), 4.69 (d, *J* = 7.7 Hz, 1H, H-1~D~),4.35 (d, *J* = 7.8 Hz, 1H, H-1~A~) and at δ 104.0 (C-1~A~), 101.2 (C-1~D~), 98.9 (C-1~B~), 98.3 (C-1~C~), 97.4 (C-1~E~) in the ^1^H and ^13^C NMR spectra, respectively\]. The *N*-phthaloyl group was removed using hydrazine hydrate and the free amine thus formed was acetylated using acetic anhydride in pyridine \[[@R35]\]. Then the removal of the benzyl group was accomplished by hydrogenation using Pearlman's catalyst \[[@R36]\]. Finally the acetates were removed by Zemplén de-O-acetylation \[[@R37]\] using sodium methoxide to afford the target pentasaccharide **1** in 58% overall yield ([Scheme 2](#C2){ref-type="fig"}).

![Reagents: (a) *N*-iodosuccinimide (NIS), TMSOTf, CH~2~Cl~2~, MS 4 Å, −30 °C, 1 h, 72%; (b) HClO~4~/SiO~2~, CH~3~CN, rt, 20 min, 85%; (c) benzoyl cyanide, DCM/pyridine, rt, 2 h, 80%; (d) *N*-iodosuccinimide (NIS), TfOH, CH~2~Cl~2~, MS 4 Å, −30 °C, 1 h, then 0 °C, 1 h, 77%; (e) NOBF~4~, Et~2~O/CH~2~Cl~2~ (3:1), −15 °C, 1 h, 75%; (f) PPh~3~, THF, 6 h, then Ac~2~O, pyridine, rt, 1 h, 84%;(g) CAN, CH~3~CN, H~2~O, rt, 1.5 h; (h) CCl~3~CN, DBU, CH~2~Cl~2~, −10 °C, 1 h; (i) NOBF~4~, CH~2~Cl~2~, −15 °C, 1 h, 70%; (j) i) NH~2~NH~2~·H~2~O, CH~3~CH~2~OH, 80 °C, 8 h, ii) acetic anhydride, pyridine, rt, 1 h; (k) H~2~, 20% Pd(OH)~2~/C, CH~3~OH, rt, 24 h; (l) 0.1 M CH~3~ONa, CH~3~OH, rt, 3 h, 58% overall yield.](Beilstein_J_Org_Chem-10-2724-g005){#C2}

Conclusion
==========

In summary, a \[3 + 2\] block glycosylation strategy has been developed to synthesize a pentasaccharide 3-aminopropyl glycoside (**1**) corresponding to the *O*-antigen of *E. coli* O117:K98:H4 strain. The in situ removal of the PMB ether in one-pot following the glycosylation reaction reduced the overall number of steps.
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